The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of AdaptHealth Corp (NASDAQ: AHCO) closed at $10.04 in the last session, down -5.28% from day before closing price of $10.60. In other words, the price has decreased by -$5.28 from its previous closing price. On the day, 1.09 million shares were traded. AHCO stock price reached its highest trading level at $10.615 during the session, while it also had its lowest trading level at $10.0.
Ratios:
We take a closer look at AHCO’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 13.49 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 5.89. For the most recent quarter (mrq), Quick Ratio is recorded 1.00 and its Current Ratio is at 1.24. In the meantime, Its Debt-to-Equity ratio is 1.44 whereas as Long-Term Debt/Eq ratio is at 1.40.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Jefferies on January 08, 2024, Downgraded its rating to Hold and sets its target price to $8 from $14.50 previously.
On November 08, 2023, BofA Securities Downgraded its rating to Underperform which previously was Neutral and also lowered its target price recommendation from $9.50 to $6.50.
Stifel Downgraded its Buy to Hold on May 10, 2023, whereas the target price for the stock was revised from $18 to $11.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 13 ’24 when WOLF DALE B bought 7,000 shares for $10.78 per share.
Rietkerk Shaw sold 25,000 shares of AHCO for $281,000 on Sep 20 ’24. The Former Chief Operating Officer now owns 212,611 shares after completing the transaction at $11.24 per share. On Sep 20 ’24, another insider, Rietkerk Shaw, who serves as the Officer of the company, bought 25,000 shares for $11.24 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AHCO now has a Market Capitalization of 1350932224 and an Enterprise Value of 3405811456. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.41 while its Price-to-Book (P/B) ratio in mrq is 0.87. Its current Enterprise Value per Revenue stands at 1.044 whereas that against EBITDA is 5.088.
Stock Price History:
Over the past 52 weeks, AHCO has reached a high of $11.90, while it has fallen to a 52-week low of $6.43. The 50-Day Moving Average of the stock is -5.66%, while the 200-Day Moving Average is calculated to be -1.36%.
Shares Statistics:
According to the various share statistics, AHCO traded on average about 1.07M shares per day over the past 3-months and 1508370 shares per day over the past 10 days. A total of 132.63M shares are outstanding, with a floating share count of 83.35M. Insiders hold about 38.05% of the company’s shares, while institutions hold 67.12% stake in the company. Shares short for AHCO as of 1730332800 were 10390517 with a Short Ratio of 9.68, compared to 1727654400 on 10293763. Therefore, it implies a Short% of Shares Outstanding of 10390517 and a Short% of Float of 10.100000000000001.
Earnings Estimates
The current market rating for AdaptHealth Corp (AHCO) reflects the collective analysis of 5.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is $0.2, with high estimates of $0.22 and low estimates of $0.18.
Analysts are recommending an EPS of between $1.0 and $0.8 for the fiscal current year, implying an average EPS of $0.93. EPS for the following year is $1.08, with 5.0 analysts recommending between $1.19 and $0.95.
Revenue Estimates
According to 8 analysts, the current quarter’s revenue is expected to be $833.54M. It ranges from a high estimate of $879.1M to a low estimate of $818.2M. As of the current estimate, AdaptHealth Corp’s year-ago sales were $858.23MFor the next quarter, 8 analysts are estimating revenue of $808.43M. There is a high estimate of $833.7M for the next quarter, whereas the lowest estimate is $776.55M.
A total of 8 analysts have provided revenue estimates for AHCO’s current fiscal year. The highest revenue estimate was $3.28B, while the lowest revenue estimate was $3.22B, resulting in an average revenue estimate of $3.24B. In the same quarter a year ago, actual revenue was $3.2BBased on 9 analysts’ estimates, the company’s revenue will be $3.35B in the next fiscal year. The high estimate is $3.46B and the low estimate is $3.28B.
